Wintermute Biomedical Inc
- Biotech or pharma, therapeutic R&D
Wintermute is a US/Australian company with a proprietary technology that harnesses the therapeutic properties of fatty acids. The company has completed a Phase Ib RCT of its lead product Solexan, a topical treatment for shingles with a novel antiviral mechanism of action.